| __timestamp | Alpine Immune Sciences, Inc. | Bio-Techne Corporation |
|---|---|---|
| Wednesday, January 1, 2014 | 12199547 | 30945000 |
| Thursday, January 1, 2015 | 16054000 | 40853000 |
| Friday, January 1, 2016 | 23316000 | 45187000 |
| Sunday, January 1, 2017 | 10626000 | 53514000 |
| Monday, January 1, 2018 | 28970000 | 55329000 |
| Tuesday, January 1, 2019 | 35847000 | 62413000 |
| Wednesday, January 1, 2020 | 27185000 | 65192000 |
| Friday, January 1, 2021 | 58742000 | 70603000 |
| Saturday, January 1, 2022 | 70243000 | 87140000 |
| Sunday, January 1, 2023 | 80904000 | 92493000 |
| Monday, January 1, 2024 | 96664000 |
Igniting the spark of knowledge
In the ever-evolving world of biotechnology, research and development (R&D) expenses are a key indicator of a company's commitment to innovation. Over the past decade, Bio-Techne Corporation and Alpine Immune Sciences, Inc. have demonstrated contrasting trajectories in their R&D investments.
From 2014 to 2023, Bio-Techne consistently increased its R&D spending, peaking in 2023 with a 200% rise from 2014. This steady growth underscores Bio-Techne's dedication to advancing its scientific endeavors. In contrast, Alpine Immune Sciences experienced a more volatile journey, with a notable surge in 2023, marking a 560% increase from its 2014 figures.
While Bio-Techne's approach reflects a stable investment strategy, Alpine's dramatic rise in recent years suggests a strategic pivot towards aggressive innovation. As we look to the future, these trends highlight the dynamic nature of R&D in the biotech sector.
Research and Development: Comparing Key Metrics for Johnson & Johnson and Alpine Immune Sciences, Inc.
Comparing Innovation Spending: Novartis AG and Bio-Techne Corporation
Research and Development Investment: Amgen Inc. vs Alpine Immune Sciences, Inc.
R&D Insights: How Bio-Techne Corporation and Lantheus Holdings, Inc. Allocate Funds
Bio-Techne Corporation or Corcept Therapeutics Incorporated: Who Invests More in Innovation?
Research and Development Investment: Bio-Techne Corporation vs CRISPR Therapeutics AG
Research and Development Expenses Breakdown: Bio-Techne Corporation vs Perrigo Company plc
Analyzing R&D Budgets: Bio-Techne Corporation vs MorphoSys AG
Analyzing R&D Budgets: BioMarin Pharmaceutical Inc. vs Alpine Immune Sciences, Inc.
Research and Development Investment: Exelixis, Inc. vs Alpine Immune Sciences, Inc.
R&D Spending Showdown: Alpine Immune Sciences, Inc. vs CRISPR Therapeutics AG
Alpine Immune Sciences, Inc. or Bausch Health Companies Inc.: Who Invests More in Innovation?